ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CDNA vs CON // EV/EBITDA & P/E VALUATION

CareDx Inc. (NASDAQ) VS. Concentra Group Holdings Parent Inc. (NYSE) • 15-METRIC TALLY: CDNA 4 — CON 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDNA VS. CON) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CDNA CON SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -8.20% 19.70% -27.90 CON /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 15.4x — TIE /valuation <GO>
Free Cash Flow Yield 0.67% 3.75% -3.08 CON /fcf-yield <GO>
Operating Margin -8.10% 15.40% -23.50 CON /operating-margins <GO>
Net Profit Margin -5.60% 7.70% -13.30 CON /net-margins <GO>
Revenue Growth (YoY) 13.80% 13.90% -0.10 CON /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.61% -0.61 CON /dividend-safety <GO>
Altman Z-Score & Debt/Equity 19.22 2.53 +16.69 CDNA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.4 61.7 +5.70 CDNA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.06 1.00 +0.06 CDNA /macro-sensitivity <GO>
Forward P/E Multiple 21.0x 26.5x -5.50 CDNA /forward-pe <GO>
Enterprise Scale & Market Cap $4.59B $5.15B -$556.4M CON /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CDNA REV CON REV CDNA GROSS % CON GROSS % CDNA FCF CON FCF
FY 2025 $379.8M $2.16B — — $24.9M $197.1M
FY 2024 $333.8M $1.90B — — $23.0M $210.3M
FY 2023 $280.3M $1.84B — — -$31.0M $151.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDNA // BETA 1.06
CON // BETA 1.00